Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leuprorelin SR + Radiotherapy vs Leuprorelin SR in Locally Advanced Prostate Cancer
NCT01122121Phase 3Completed
- Sponsor
- Takeda
- Start
- Mar 2000
- Primary completion
- Dec 2008
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of leuprolide in prostate cancer (PCa), sponsored by Takeda. Started Mar 2000; status: completed.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01122121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01122121.